Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers
Mason L, Shic F, Falck-Ytter T, Chakrabarti B, Charman T, Loth E, Tillmann J, Banaschewski T, Baron-Cohen S, Bölte S, Buitelaar J, Durston S, Oranje B, Persico A, Beckmann C, Bougeron T, Dell’Acqua F, Ecker C, Moessnang C, Murphy D, Johnson M, Jones E. Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers. Molecular Autism 2021, 12: 74. PMID: 34911565, PMCID: PMC8672507, DOI: 10.1186/s13229-021-00476-0.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAutism Spectrum DisorderAutistic DisorderBiomarkersCase-Control StudiesChildHumansSeverity of Illness IndexYoung AdultConceptsAutism spectrum disorderBiological motion preferenceBiological motionASD groupNeurotypical participantsMotion preferencesSocial-communicative symptomsSocial-communicative skillsBiological motion stimuliSocial brain functionSocial brain regionsLow-IQ individualsLow average IQNeurocognitive mechanismsAutistic differencesIndividual differencesMotion stimuliControl stimuliLater symptomatologySpectrum disorderAverage IQCommunicative skillsVisual preferenceSocial autismControl participants